Eric D. Shaff, CFO and EVP at Seres Therapeutics, Inc. (MCRB), sold 7,663 shares at $25.13 ($202K) on 2016-03-31, disclosed to the SEC on 2016-04-04.
Open-market sale of $202k MCRB by CFO and EVP. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.13 | 1,095 | $28K | 13.7% |
| 2 | $26.50 | 6,568 | $174K | 86.3% |
| Total | $26.30 avg | 7,663 | $202K | 100% |
| Filing → |
| MCRB | SELL | 2016-04-06 | $189K | — | Filing → |
| MCRB | SELL | 2016-03-29 | $132K | — | Filing → |